CSIMarket


Molecular Partners Ag  (MOLN)
Other Ticker:  
 

Molecular Partners Ag

MOLN's Fundamental analysis








Looking into Molecular Partners Ag growth rates, revenue grew by 1843.82 % in IV. Quarter 2022 from the same quarter a year ago. Ranking at No. 18

Biotechnology & Pharmaceuticals industry recorded deterioration of revenues by -4.45 %

Molecular Partners Ag realized net income compared to net loss a year ago in IV. Quarter 2022

More on MOLN's Growth


Molecular Partners Ag
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Molecular Partners Ag PEG ratio is at -0.01 Company is currently trading with Price to Cash flow multiple of 2.78 in trailing twelve-month period.
Company
1.69
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.05.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.53.


More on MOLN's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 7.07

Molecular Partners Ag
current PE on trailing twelve month basis is above Biotechnology & Pharmaceuticals industry average.

Molecular Partners Ag PEG ratio is at -0.01 Company is currently trading with Price to Cash flow multiple of 2.78 in trailing twelve-month period.
Company
1.69
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 1.05.
Biotechnology & Pharmaceuticals industry's Price to Sales ratio is at 5.53.

Molecular Partners Ag Price to Book Ratio is at 0.85 higher than Indusry Avg. of -0.02, and higher than S&P 500 Avg. of -0.01

More on MOLN's Valuation

  Market Capitalization (Millions $) 200
  Shares Outstanding (Millions) 33
  Employees -
  Revenues (TTM) (Millions $) 190
  Net Income (TTM) (Millions $) 118
  Cash Flow (TTM) (Millions $) 72
  Capital Exp. (TTM) (Millions $) -1
  Total Debt (Millions $) -
  Dividend TTM ($) 0 $
  Dividend Yield TTM (%) -
  Revenue/Employee (TTM) $ -
  Net Income/Employee(TTM) $ -
  Receivable Turnover Ratio (TTM) -
  Tangible Book Value (Per Share $) 7.07

  Market Capitalization (Millions $) 200
  Shares Outstanding (Millions) 33
  Employees -
  Revenues (TTM) (Millions $) 190
  Net Income (TTM) (Millions $) 118
  Cash Flow (TTM) (Millions $) 72
  Capital Exp. (TTM) (Millions $) -1


    MOLN's Profitability Comparisons
Molecular Partners Ag